Related Experiment Video

Updated: Jul 8, 2025

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

3.3K

Patients with COVID-19 Pneumonia Admitted to an Intensive Care Unit (ICU) at a Community Hospital in Flint, Michigan,

Atefeh Kalantary1, Olga J Santiago-Rivera2, Arunima Dutta3

  • 1Medical Director Menalam Health Services PC, Simi Valley, CA.

Spartan Medical Research Journal
|December 12, 2023
PubMed
Abstract

Insights

In critically ill COVID-19 patients, type 2 diabetes and hypertension, not race, independently increased the risk of intensive care unit (ICU) mortality. These comorbidities are crucial factors in COVID-19 outcomes.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • COVID-19 pandemic highlighted racial disparities in outcomes.
  • Ongoing debate exists regarding race as an independent risk factor for COVID-19 mortality.
  • Michigan reported significant geographic and racial disparities in COVID-19 cases.

Purpose of the Study:

  • To examine characteristics of early COVID-19 intensive care unit (ICU) patients in Flint, Michigan.
  • To identify factors associated with ICU mortality in this cohort.
  • To specifically investigate the role of race in ICU mortality.

Main Methods:

  • Cross-sectional study of adult patients with severe COVID-19 pneumonia admitted to ICU.
  • Data collected between March and May 2020.
  • Analyzed demographic characteristics, comorbidities, treatments, and complications as potential risk factors.

Main Results:

  • The study included 48 patients (51.1% Black adults, 56.2% male), with a 51.1% ICU mortality rate.
  • Age, type 2 diabetes, and essential hypertension were independently associated with increased ICU mortality.
  • Race was not found to be significantly associated with ICU mortality in this cohort.

Conclusions:

  • Comorbid conditions like type 2 diabetes and hypertension are linked to poorer outcomes in severe COVID-19 pneumonia.
  • This study offers insights into the mortality of an early ICU COVID-19 patient cohort in Flint, Michigan.
  • Findings underscore the importance of managing comorbidities in critically ill COVID-19 patients.
Keywords:
FlintIntensive Care UnitKEYWORDS: COVID-19in-hospital mortalitypneumonia

More Related Videos

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.8K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.2K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
242
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
239
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
333
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
283
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
159
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
176